TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 107 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q3 2015. The put-call ratio across all filers is 1.99 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $2,518,000 | -14.8% | 657,496 | -4.3% | 0.08% | -24.1% |
| Q2 2016 | $2,954,000 | +12.3% | 686,921 | +20.9% | 0.11% | +12.5% |
| Q1 2016 | $2,630,000 | -54.2% | 568,001 | -0.9% | 0.10% | -51.5% |
| Q4 2015 | $5,748,000 | -9.4% | 573,101 | -32.6% | 0.20% | +1.0% |
| Q3 2015 | $6,345,000 | -81.0% | 850,601 | +20.5% | 0.20% | -79.3% |
| Q2 2015 | $33,474,000 | +26.8% | 705,601 | -2.1% | 0.95% | +25.4% |
| Q1 2015 | $26,409,000 | +7.5% | 720,781 | +16.5% | 0.76% | +5.4% |
| Q4 2014 | $24,575,000 | +299.5% | 618,860 | +100.7% | 0.72% | +277.4% |
| Q3 2014 | $6,152,000 | – | 308,360 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVEY CAPITAL MANAGEMENT INC | 354,300 | $7,068,000 | 2.77% |
| Opaleye Management Inc. | 169,700 | $3,385,515,000 | 2.64% |
| Broadfin Capital, LLC | 959,247 | $19,137,000 | 2.01% |
| Novo Holdings A/S | 900,000 | $17,955,000 | 1.75% |
| Eventide Asset Management | 300,900 | $6,003,000 | 0.84% |
| EAM Investors, LLC | 152,595 | $3,044,000 | 0.62% |
| COLUMBIA PARTNERS L.L.C. INVESTMENT MANAGEMENT | 497,858 | $9,932,000 | 0.51% |
| Granite Point Capital Management, L.P. | 40,000 | $798,000 | 0.40% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 450,191 | $8,981,000 | 0.33% |
| TFS CAPITAL LLC | 133,070 | $2,655,000 | 0.23% |